Hutchison China MediTech Ltd ADR buy Bank of America Co.
Start price
22.07.25
/
50%
€14.60
Target price
22.07.26
€23.95
Performance (%)
-21.23%
Price
10.12.25
€11.60
Summary
This prediction is currently active. The price of Hutchison China MediTech Ltd ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -21.23%. This prediction currently runs until 22.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hutchison China MediTech Ltd ADR | -0.840% | -0.840% |
| iShares Core DAX® | 1.803% | 0.496% |
| iShares Nasdaq 100 | 0.429% | -0.410% |
| iShares Nikkei 225® | 0.708% | -3.799% |
| iShares S&P 500 | 0.288% | -0.218% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Hutchison China MediTech Ltd ADR diskutieren
HUTCHMED (China) Limited Sponsored ADR (NASDAQ: HCM) had its price target raised by analysts at Bank of America Corporation from $27.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for HCM provided by MarketBeat